Allografts
All Leader Biomedical’s allografts are processed with our proprietary eCOO® Technology, a mild and efficient platform using supercritical carbon dioxide (scCO2) to clean, sterilise, and impregnate human and animal-derived bone and tissue with limited use of chemicals.
scCO2 minimally affects the structural integrity of bone and tissue grafts when compared to conventional processing techniques. Furthermore, scCO2 treatment removes medullary tissues responsible for adverse immune response.